Attenuation of Salt-Induced Cardiac Remodeling and Diastolic Dysfunction by the GPER Agonist G-1 in Female mRen2.Lewis Rats by Jessup, Jewell A. et al.
Attenuation of Salt-Induced Cardiac Remodeling and
Diastolic Dysfunction by the GPER Agonist G-1 in Female
mRen2.Lewis Rats
Jewell A. Jessup
1., Sarah H. Lindsey
2., Hao Wang
3, Mark C. Chappell
1,2, Leanne Groban
2,3*
1The Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States of America, 2The
Hypertension and Vascular Research Center, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States of America, 3The Department of
Anesthesiology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States of America
Abstract
Introduction: The G protein-coupled estrogen receptor (GPER) is expressed in various tissues including the heart. Since the
mRen2.Lewis strain exhibits salt-dependent hypertension and early diastolic dysfunction, we assessed the effects of the
GPER agonist (G-1, 40 nmol/kg/hr for 14 days) or vehicle (VEH, DMSO/EtOH) on cardiac function and structure.
Methods: Intact female mRen2.Lewis rats were fed a normal salt (0.5% sodium; NS) diet or a high salt (4% sodium; HS) diet
for 10 weeks beginning at 5 weeks of age.
Results: Prolonged intake of HS in mRen2.Lewis females resulted in significantly increased blood pressure, mildly reduced
systolic function, and left ventricular (LV) diastolic compliance (as signified by a reduced E deceleration time and E
deceleration slope), increased relative wall thickness, myocyte size, and mid-myocardial interstitial and perivascular fibrosis.
G-1 administration attenuated wall thickness and myocyte hypertrophy, with nominal effects on blood pressure, LV systolic
function, LV compliance and cardiac fibrosis in the HS group. G-1 treatment significantly increased LV lusitropy [early mitral
annular descent (e9)] independent of prevailing salt, and improved the e9/a9 ratio in HS versus NS rats (P,0.05) as
determined by tissue Doppler.
Conclusion: Activation of GPER improved myocardial relaxation in the hypertensive female mRen2.Lewis rat and reduced
cardiac myocyte hypertrophy and wall thickness in those rats fed a high salt diet. Moreover, these advantageous effects of
the GPER agonist on ventricular lusitropy and remodeling do not appear to be associated with overt changes in blood
pressure.
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Introduction
Hypertension in postmenopausal women results in left ventric-
ular hypertrophy (LVH), a major causative factor for reductions in
both myocardial relaxation and diastolic compliance which are
key components of diastolic dysfunction [1–3]. In addition to the
loss of estrogen, salt sensitivity of blood pressure in premenopausal
normotensive and hypertensive women has been attributed to an
increased risk of subsequent age-related hypertension [4]. Salt-
sensitive hypertensive patients have a higher incidence of LVH
than salt-resistant hypertensive individuals [5], further increasing
their predisposition for the development of diastolic heart disease.
Indeed, the evolution of LVH differs between pre-and postmen-
opausal women, with a greater induction of hypertrophy when
circulating estrogen levels are reduced [6]. While evidence suggests
that estrogen may protect the premenopausal heart from the
deleterious effects of hypertension and salt-induced LV remodeling
[7,8], the mechanisms and receptors involved remain unclear.
Estrogen attenuates the development of cardiac hypertrophy and
fibrosis through activation of steroid receptors ERa and ERb located
on myocytes, fibroblasts, and the extracellular matrix [9]. Estrogen
also interacts with the novel G protein-coupled receptor GPR30 or
GPER, located at the cell membrane and endoplasmic reticulum
[10,11]. Signaling pathways for GPER include mitogen-activated
protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K), which
can modulate nuclear transcriptional events similar to the classic ERs
[12]. GPER binds estradiol at a similar affinity as ERa and ERb and
exerts comparable actions on calcium mobilization and PI3K
activation [13]. GPER activation improves contractile function and
reduces infarct size in isolated rat and mouse hearts subjected to
ischemia/reperfusion injury[14]; however, the precise rolefor GPER
in cardiac remodeling is not known.
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GPER agonist G-1 significantly reduces hypertension in the
estrogen depleted mRen2.Lewis congenic rat [15] but fails to
attenuate the elevated systolic blood pressure characteristic of
estrogen-intact littermates. In addition to estrogen-sensitivity,
mRen2.Lewis females also exhibit salt-sensitivity whereby high
sodium intake in estrogen-replete mRen2.Lewis increases blood
pressure, initiates LV hypertrophy, and impairs diastolic function
[16–19]. As our preliminary data indicate that high salt increased
GPER gene expression within the heart, we hypothesized that
chronic GPER activation attenuated changes in LV remodeling
due to prolonged intake of a high salt diet.
Materials and Methods
Animals
Female mRen2.Lewis rats were obtained from the Hyperten-
sion and Vascular Research Center Congenic Colony of Wake
Forest University School of Medicine and all studies were
approved by the institution’s Animal Care and Use Committee
under protocol #A08-198. Rats were individually housed in an
Association for Assessment and Accreditation of Laboratory
Animal Care-approved, temperature (2262uC) and light (12 h
light/dark cycle) controlled facility with ad libitum access to rat
chow and tap water.
Experimental protocol
The mRen2.Lewis rats were fed either a normal salt (0.5%
sodium; NS, n=12) or high salt (4% sodium; HS, n=10) diet
(Harlan TEKLAB, Madison, WI) for 10 weeks starting at 5 weeks
of age. The percentage of sodium was chosen based upon its
known effects on cardiovascular pathogenesis in the mRen2.Lewis
female rat, as originally determined [17–19]. At 13 weeks of age,
when salt-induced blood pressure elevations plateau [18], animals
received either the selective GPER agonist G-1 (NS, n=5; HS,
n=5) or vehicle (DMSO/EtOH; NS, n=7; HS, n=5) adminis-
tered via osmotic minipump at 40 nmol/kg/hr for 2 weeks (Alzet
Model 2ML2, Durect Corporation, Cupertino, CA). The dose of
G-1 used was based upon the initial study conducted in our
laboratory that demonstrated significant blood pressure reductions
over a two week period using 40 nmol/kg/hr in estrogen-deplete
mRen2.Lewis female rats [15]. Systolic blood pressure was
measured throughout the study using tail-cuff plethysmography
(Narco Bio-systems, Houston, TX) as previously described and
validated versus telemetry [20].
The pressures were recorded in pre-trained rats while lightly
restrained and warmed (35uC). At the end of the 2-week treatment
period, left ventricular dimensions and left ventricular function
were assessed by M-mode and Doppler echocardiography,
respectively. Once the experiments were terminated, the hearts
were removed and weighed with a portion being submerged in
10% formalin for histology.
Echocardiographic studies
Echocardiography of all animals was performed at the end of
week 15 using a Philips 5500 or Envisor CD echocardiograph
(Philips Medical Systems, Andover, MA) and a 12 MHz phased
array probe. All measurements were made in accordance with the
conventions of the American Society of Echocardiography, and
were conducted by the same investigator who was blinded to the
experimental groups. For the procedure, animals were lightly
sedated with 4% isoflurane, and then maintained at 2.0%
isoflurane. Left ventricular end-diastolic and end-systolic diameters
(LVEDD and LVESD, respectively), LV posterior wall thickness
(PWT), and anterior wall thickness (AWT) were measured from
midpapillary, short-axis images obtained by M-mode echocardi-
ography. The percentage of LV fractional shortening (%FS), an
index of contractile function, was calculated as FS (%) =
[(LVEDD – LVESD)/LVEDD]6100. LV mass was calculated
using a standard cube formula, which assumes a spherical LV
geometry according to the formula: LV mass (LVmass) =
1.046[[LVEDD + PWT + AWT]
3 – LVEDD], where 1.04 is
the specific gravity of muscle. Relative wall thickness (RWT) was
calculated as: 26PWT/LVEDD. Mitral inflow measurements of
early filling velocity (Emax), deceleration slope of early filling
velocity (Edec slope), and deceleration time of early filling flow
velocity (Edec time) were obtained using pulsed Doppler, with the
sample volume placed at the tips of mitral leaflets from an apical
four-chamber orientation. The following measurements were
made from the septal mitral annular velocity by tissue Doppler
imaging (DTI): early diastolic (e9), late diastolic (a9), and the ratio,
e9/a9. The early filling velocity-to-early mitral annular velocity
ratio (E/e9) was used as a measure of filling pressure. All
measurements were performed with an off-line analysis system
(Xcelera 3.1, Koninklijke Philips Electronics, Netherlands) by the
masked investigator. An average of at least five consecutive cardiac
cycles to minimize beat-to-beat variability was used for all
measured and calculated systolic and diastolic indices.
Histopathology
Heart specimens were fixed for 24 h in 10% formalin, then
dehydrated in graded ethanols and embedded into paraffin blocks.
4 mm sections were mounted on positive-charged slides and
stained with Picrosirius red (PSR) to evaluate collagen deposition
within the tissue. Images of interstitial and perivascular collagen
were captured using both bright-field and polarized dark-field
microscopy in order to clearly differentiate the Sirius red bound
collagen from other cellular structures [21,22]. The ratios of
collagen positive stained pixels to unstained pixels were calculated
using Adobe Photoshop Creative Suite 3. Myocyte cross-sectional
area was measured from slides stained with hematoxylin and eosin.
One hundred cardiomyocytes from each section (25 from each of
LV anterior wall, posterior wall, free wall and septum) were
analyzed at 4006 magnification using Simple PCI 6.0 software
connected to a Leica DM4000B (Bannockburn, IL) and an
Olympus polarizing microscope system (Center Valley, PA),
respectively. Bright field photomicrographs were captured with a
Leica DFC digital camera and processed using Leica Application
Suite software, while polarized images were taken using Diagnostic
Instruments Inc. Digital SPOT RT, 3-pass capture, thermoelec-
trically cooled charge-coupled camera (Sterling Heights, MI) and
processed using the SPOTH Advanced software. A blinded
observer took 2 images from each of 4 randomized quadrant
fields totaling 8 images per section under bright field and with
polarization magnified 200-times. The digitized images of equal
pixel composition were analyzed using Adobe Photoshop Creative
Suite 3. The quantified collagen content was determined as a ratio
of PSR-stained pixels divided by total pixels.
Immunohistochemistry
Heart sections mounted on slides were blocked with 0.1%
Tween, 1% bovine serum albumin, and 5% normal donkey serum.
Anti-GPER (MBL, Woburn, MA) was diluted 1:250 in blocking
buffer and incubated overnight at 4uC. For a negative control, the
primary antibody was pre-incubated with the blocking peptide for
1 h at 25uC and centrifuged before being applied to tissue sections.
Biotinylated goat anti-rabbit (VectorLabs, Burlingame, CA) was
diluted 1:400 in the blocking buffer and applied for 1 h at 25uC.
GPER and LV Anti-Remodeling
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complex kit (VectorLabs) and 0.1% diaminobenzene (Sigma, St.
Louis, MO). Slides were counterstained with hematoxylin (Sigma,
St. Louis, MO).
Analysis of gene expression by quantitative real-time PCR
Real-time PCR was used to detect cardiac mRNA expression
levels for GPER and brain natriuretic peptide (BNP). Total RNA
was extracted from frozen, pulverized left ventricular tissue from
each rat using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA)
and processed according to the recommendations of the
manufacturer. The quality and quantity of RNA samples were
determined by spectrometry and agarose gel electrophoresis.
Complimentary first strand DNA was synthesized from oligo (dT)
primed total RNA using the Omniscript RT kit (Quiagen Inc, CA,
USA). Relative quantification by real-time PCR was performed
using SYBR Green PCR kit (Quiagen, CA, USA). Amplification
and detection were performed with the use of the ABI7500
Sequence Detection System (Applied Biosystems). PCRs were
carried out in duplicate. Only one peak from the dissociation curve
was found from each pair of oligonucleotide primers tested. In
each PCR run, a no-template-control was included to check for
any contamination disturbing PCR. It was also confirmed that no
amplification occurred when samples were not subjected to reverse
transcription. Sequence-specific oligonucleotide primers were
designed according to published GenBank (www.ncbi.nlm.nih.
gov/Genbank) sequences and confirmed with OligoAnalyzer 3.0
(Table 1). The relative target mRNA levels in each sample were
normalized to S16 ribosomal RNA. Expression levels are given
relative to the geometric mean of the control group.
Statistical analysis
All values are expressed as mean 6 SEM. Blood pressures were
analyzed by two-way ANOVA, followed by the Bonferroni post-
hoc analysis. Data from physical characteristics, echocardiography,
and histopathology were compared using two-way ANOVA to
determine significant effects of either salt or G-1. If the interaction
was significant, between group comparisons were conducted by
using the Bonferroni post-hoc test. Data from real-time PCR was
analyzed by performing one-way ANOVA followed by Tukey’s
post-hoc test. All data were analyzed using GraphPad PRISM
Version 5 (GraphPad, San Diego, CA, USA) with P,0.05
considered statistically significant.
Results
As previously reported [18], the chronic high salt diet
significantly increased systolic blood pressure in the female
mRen2.Lewis by nine weeks of age (215619 vs. 147627 mmHg;
P,0.001). To determine whether cardiac GPER gene expression
was altered by high salt, we utilized real-time PCR to compare
GPER mRNA in hearts from female mRen2.Lewis rats fed a
normal salt (NS) or high salt (HS) diet. GPER mRNA was
increased by 80% in HS versus NS hearts (Figure 1A), prompting
further investigation of the role of GPER in salt-induced cardiac
remodeling and diastolic dysfunction. Immunohistochemistry of
fixed heart sections using an antibody directed against GPER
showed prominent staining in cardiomyocytes (Figure 1B). Stain-
ing was attenuated by pre-incubation of the primary antibody with
the immunizing peptide. As shown in Figure 1C, analysis of
cardiac homogenates by Western blot using the same antibody
revealed a single immunoreactive band at ,48 kDa, similar to
that reported in aortic tissues [15]. This molecular weight of
GPER is slightly higher than the predicted molecular weight of
38 kDa and is likely due to post-translational glycosylation [10].
Two-weeks of the GPER agonist G-1 infusion in either the HS
or the NS group did not significantly alter systolic blood pressure
[G-1: F(1,18)=3.88, P=0.064), despite the fact that the HS diet
markedly exacerbated systolic hypertension in comparison to NS
(Figure 2). The lack of a blood pressure response to G-1 in the
intact mRen2.Lewis females fed a NS diet is consistent with
previous results in the female mRen2.Lewis strain [15].
The effects of HS on cardiac hypertrophy and body weight
change, in the presence or absence of G-1, are shown in Table 2.
The body weight of HS females (20367 grams) was not
significantly different from NS rats (21664 grams) after 8-weeks
of the dietary intervention. The weight gain that occurred over the
2-week infusion period was independent of treatment (G-1:
F(1,18)=0.22, P=0.64). As expected, heart weight normalized
to body weight was greatest in HS rats. Although GPER activation
did not influence cardiac mass in NS females, salt-induced cardiac
hypertrophy was attenuated by G-1 (Salt 6G-1: F(1,18)=7.404,
P,0.01). Microscopic examination of ventricular cross-sections
revealed a 27% increase in overall myocyte cross-sectional area
(P,0.001) in HS rats compared to NS littermates, and this salt-
induced effect was attenuated by G-1 administration (P,0.05)
(Figures 3A and 3B). These observations were further supported
by a salt-induced increase in BNP gene expression, a biomarker of
cardiomyocyte hypertrophy. HS increased cardiac BNP mRNA
by two-fold, and G-1 treatment attenuated this effect (Figure 3C).
Long-term HS significantly increased interstitial and perivascu-
lar collagen deposition as measured by Picrosirius Red staining
(Figure 4). The increase in cardiac fibrosis resulting from the HS
diet was not affected by G-1 administration (P.0.05). Cardiac
collagen gene expression was also not altered by G-1 (data not
shown). G-1 did not influence the deposition of cardiac collagen in
NS animals.
Left ventricular wall dimensions and systolic parameters are
summarized in Table 3. M-mode examination revealed that
LVESD was significantly increased by HS and was associated with
Table 1. Sequence of PCR Primers.
Gene Oligonucleotide Sequence GenBank Locus Position Product size (bp)
S16 GGAGAGATTTGCTGGTGTGG
TCCGATCGTACTGGATGAGG
BC159438.1 223-242
395-376
120
GPER TCTACCTAGGTCCCGTGTGG
AGGCAGGAGAGGAAGAGAGC
NM_133573.1 86-105
236-217
151
BNP GCCAGTCTCCAGAACAATCC
CCTTGGTCCTTTGAGAGCTG
NM_031545.1 155-174
251-232
97
S16; GPER, G protein-coupled estrogen receptor; BNP, brain natriuretic peptide.
doi:10.1371/journal.pone.0015433.t001
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wall thickness was greater in HS rats when compared to NS
littermates. While salt contributed to 30% of the variance in wall
thickness, G-1 also had a specific effect, accounting for 15% of the
total variance in RWT. Importantly, G-1 treatment decreased wall
thickness, despite minimal differences in blood pressure between
salt-fed groups.
In addition to salt-associated changes in cardiac geometry,
diastolic parameters were also negatively affected by the HS diet
(Table 4). Conventional Doppler showed evidence of reduced
ventricular compliance in HS rats as manifested by a shorter
deceleration time of the E wave and an increased early
deceleration slope as compared to NS rats. G-1 administration
minimally affected these early mitral inflow parameters, likely due
to a G-1 6 salt interaction on heart rate (G-1 6 Salt:
F(1,18)=6.70, P=0.019). Indeed, conventional transmitral Dopp-
ler measures of diastolic function are load and heart rate
dependent [23–26]. Reductions in preload can lead to reductions
in early transmitral filling velocity and in the ratio of early-to-late
LV filling (E/A). Conversely, increases in preload entail a
transition towards a pseudonormal pattern (e.g., E.A) or reduced
compliance. Heart rate and rhythm are other factors that affect
LV diastolic filling, independent of diastolic function. For instance,
at higher heart rates (shorter diastolic filling time), the late mitral
inflow velocity (A), may be increased as it becomes superimposed
on the E deceleration slope. When the diastolic interval is very
short (e.g., rat heart rates .300 beats/min), there could be fusion
of the E and A velocities. The inclusion of tissue Doppler,
however, facilitates the assessment of diastolic function since it is
less affected by loading conditions than conventional Doppler
[27], and the tissue Doppler surrogate of LV filling pressure, E/e9,
has been shown to be relatively independent of heart rate and
rhythm abnormalities [28–30]. In the present study, diastolic
function as assessed by tissue Doppler showed that G-1
administration significantly improved myocardial relaxation in
both diet regimens, as manifested by an increase in mitral annular
descent (e9) (Table 3). GPER activation, irrespective of salt,
accounted for 41% of the variance in e9, whereas salt alone
contributed to just 10% of the variance in this measure of
ventricular lusitropy. Another manifestation of myocardial relax-
ation, the ratio of early to late mitral annular velocity, was
increased with G-1 treatment in the HS group while the GPER
agonist had minimal effects in NS-fed rats (Figure 5). Specifically,
the combination of G-1 and HS had a synergistic effect on e9/a9,
Figure 1. Cardiac GPER expression increases in salt-fed mRen2.Lewis females. a. Cardiac GPER gene expression in female mRen2.Lewis rats
fed a normal salt (NS) or high salt (HS) diet determined by real-time PCR and expressed as the ratio of GPER mRNA to S16 ribosomal RNA. Values are
mean 6 SEM; ** P,0.01. b. Left, representative GPER immunostaining in a cross section of the heart from an intact mRen2.Lewis female. Right,
representative control section stained with pre-adsorbed primary antibody. c. Full-length immunoblot of cardiac membranes showing the specificity
of the primary antibody using for immunohistochemistry as evidenced by a single band corresponding to the appropriate molecular weight of GPER
(,50 kDa).
doi:10.1371/journal.pone.0015433.g001
Figure 2. G1 treatment for two weeks does not affect salt-
associated increases in blood pressure. Tail-cuff systolic blood
pressure in conscious female mRen2.Lewis rats fed a normal salt (NS) or
high salt (HS) diet over the course of the experiment. Arrow indicates
time of pump insertion for 14-day delivery of either G-1 or vehicle (VEH).
Values are mean 6 SEM; * P,0.05 compared to NS (Salt effect).
doi:10.1371/journal.pone.0015433.g002
GPER and LV Anti-Remodeling
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of diastolic function.
Discussion
To our knowledge, this is the first study investigating the cardiac
structural and functional effects of in vivo activation of the novel
receptor GPER in the female mRen2.Lewis rat, a congenic rodent
model of salt-sensitive hypertension and early diastolic dysfunction
[17–19]. The most significant effects of G-1 treatment were
attenuation of salt-induced LV wall thickness, myocyte hypertro-
phy, and early diastolic function via mechanisms that are
independent of systemic blood pressure. We also found that GPER
activation improved LV lusitropy in both the presence and absence
of high salt. Given that G-1 is not a ligand for estrogen receptors a
or b [31] and that GPER immunostaining was present on
cardiomyocytes, these findings suggest important anti-remodeling
and lusitropic roles for GPER that likely reflect direct actions on
cardiac tissue. Indeed, endogenous estrogen could contribute to
GPER-mediated cardioprotection, since estradiol binds GPER with
an affinity similar to G-1 [31]. The focus on diastolic dysfunction
pathogenesis and cardiac remodeling is of particular importance in
the aging female population given the clinical evidence of a
preponderance of heart failure with normal ejection fraction
[2,32,33]. In addition, there are no established therapies to
optimally treat this form of diastolic heart disease or prevent its
occurrence [34].
Chronic high salt intake stimulates structural changes in the left
ventricle through pressure overload and via direct myocardial
effects [35]. LV remodeling is characterized by an increase in LV
mass and fibrosis, with the myocyte and fibroblast as the
predominant cell types involved [36]. The mRen2.Lewis female
rat exhibited salt-dependent increases in blood pressure and
cardiac hypertrophy with concomitant perivascular collagen
deposition, consistent with our previous work in this strain
[18,19]. While the presence of endogenous estrogen in the intact
mRen2.Lewis female affords some cardioprotection in the face of
high salt [19], cardiac GPER gene expression was significantly
increased by HS, indicating a role for this receptor in salt-induced
cardiac remodeling. The additive benefit of G-1 administration
late in the remodeling process and the localization of GPER on
cardiac myocytes suggest cardioprotective actions independent of
ERa or ERb [37].
Estrogen retards the progression of hypertension [6], delays or
attenuates the development of cardiac hypertrophy [2,38], limits
fibrosis, and reduces the activation of the renin-angiotensin system
[39–41] in salt-sensitive experimental models and in humans.
Estrogen attenuates myocyte growth and LVH by blocking
MAPK activity [42] and various protrophic components of the
cardiac renin-angiotensin system [43–45]. The present data
demonstrate a protective effect of GPER activation on salt-
induced myocyte growth and myocardial hypertrophy, as defined
by heart weight-to-body weight ratio and relative wall thickness.
These protective effects of G-1 were pressure-independent and
were accompanied by attenuation of the salt-induced stimulation
Table 2. Physical Characteristics of the Four Experimental
Groups.
P-value
Normal SaltHigh Salt Salt G-1 Interaction
Body weight gain, %
Vehicle
G-1
2.1660.8
2.2460.8
3.0060.8
3.7560.9
0.20 0.64 0.71
Whole heart weight, g
Vehicle
G-1
0.7160.01
0.7560.02
1.0960.05
1.1160.05
,0.01 0.39 0.77
Heart/body weight, mg/g
Vehicle
G-1
3.2860.07
3.3760.09
5.3960.08
4.9860.13
,0.01 0.10 0.01
Data are expressed as mean 6 SEM. Body weight gain represents the percent
change in weight from week 13 (prior to pump insertion) to week 15.
doi:10.1371/journal.pone.0015433.t002
Figure 3. GPER activation with G1 limits salt-induced myocyte hypertrophy. a. Representative hematoxylin and eosin staining outlining
cardiomyocytes. b. Quantification of myocyte cross-sectional area. Data represent mean 6 SEM. *** P,0.001 (Salt effect); # P,0.05 (G-1 effect). c.
Cardiac BNP gene expression determined by real-time PCR and expressed as the ratio of BNP mRNA to S16 ribosomal RNA. # P,0.05 (G-1 effect).
doi:10.1371/journal.pone.0015433.g003
GPER and LV Anti-Remodeling
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a biomarker of cardiomyocyte hypertrophy and cardiac dysfunc-
tion [46,47].
Estrogen’s anti-remodeling effects also involve its actions on
fibroblasts and the cardiac extracellular matrix, composed
primarily of collagen proteins. A shift in fibrillar collagen from
type III (‘‘youthful’’ collagen) to type I, for example, is the primary
determinant of LV diastolic stiffness [48]. In aged [49] and salt-
sensitive rats [50], ovariectomy increases collagen I and reduces
collagen III and the metalloproteinase that degrades collagen,
MMP2, while estrogen replacement reverses these effects [49].
Likewise, we previously showed limited interstitial cardiac collagen
deposition in the estrogen-intact HS mRen2.Lewis when com-
pared to ovariectomized HS and NS littermates [19]. In the
present study, G-1 did not alter perivascular collagen deposition;
however, the lack of a potent G-1-mediated anti-fibrotic effect
under high salt conditions may be obscured by the presence of
endogenous estrogen. In addition, if the extent of cardiac collagen
is a reflection of exacerbated hypertension, we would expect this
fibrosis to persist given that G-1 had minimal effects on blood
pressure. On the contrary, the absence of a G-1 effect on collagen
deposition may imply that the anti-fibrotic effects of estrogen are
not mediated by GPER.
Consistent with our earlier study, salt-loading in the estrogen-
intact mRen2.Lewis rat resulted in early diastolic dysfunction [19].
The increasing degree of concentric remodeling with HS was
associated with a decreased time required for deceleration of the
early diastolic flow (Edec time), which is indicative of reduced LV
compliance [51]. Additionally, HS reduced early diastolic
myocardial velocity, or e9, but did not increase LV filling pressure,
as estimated by the E/e9 ratio. Although salt-induced cardiac
hypertrophy and reduced systolic function adversely impacted LV
lusitropy, endogenous estrogen most likely blunted the effect [19].
Along with its anti-remodeling action, the GPER agonist
enhanced myocardial relaxation. Late administration of G-1
increased early mitral annular descent (e9) in NS and HS
mRen2.Lewis rats. While reductions in vascular stiffening and
lessening of hypertension can enhance diastolic function, systolic
blood pressures were not overtly reduced by G-1 in this study. The
increased e9 to a9 ratio further corroborates the direct lusitropic
action of G-1 in the HS females. Importantly, an e9 to a9 ratio
.1.0 is considered normal, with a reduced ratio (as in the HS
vehicle group) indicating impaired early diastolic relaxation
[52,53]. Whether improvements in intracellular calcium handling
and/or increased expression of calcium regulatory proteins partly
explain the G-1-mediated lusitropic benefit remains to be
investigated. Indeed, the trend toward enhanced systolic function
in G-1 treated rats, particularly those fed NS, could have had
positive influence on diastolic function. Two recent studies have
shown that GPER activation improves contractile function and
reduces infarct size in isolated hearts subjected to ischemia/
reperfusion injury [14,54].
Table 3. Cardiac Geometry and Systolic Parameters.
P-value
Normal SaltHigh Salt Salt G-1 Interaction
LV mass
Vehicle
G-1
3.6760.35
2.8560.28
7.5560.46
7.5660.79
,0.001 0.423 0.410
LVEDd, cm
Vehicle
G-1
0.6660.02
0.6860.02
0.6660.02
0.7360.02
0.174 0.045 0.213
LVESd, cm
Vehicle
G-1
0.3560.01
0.3160.03
0.4360.01
0.4660.02
,0.001 0.930 0.066
RWT
Vehicle
G-1
0.5260.05
0.4660.05
0.7060.03
0.5660.03
,0.001 0.042 0.388
%FS
Vehicle
G-1
4661
5463
3562
3762
,0.001 0.053 0.181
Data are expressed as mean 6 SEM. LV mass = left ventricular mass; LVEDd =
left ventricular end-diastolic dimension; LVESd = left ventricular end-systolic
dimension; RWT = relative wall thickness; %FS = percent fractional shortening.
doi:10.1371/journal.pone.0015433.t003
Table 4. Heart Rate and Diastolic Parameters.
P-value
Normal Salt High Salt Salt G-1 Interaction
Heart rate, bpm
Vehicle
G-1
37465
39263
42269
403610
,0.001 0.945 0.019
Emax, cm/s
Vehicle
G-1
6664
7162
6763
7263
0.832 0.153 0.948
E dec time, sec
Vehicle
G-1
0.05360.003
0.04660.004
0.03360.002
0.03260.002
,0.001 0.199 0.218
E dec slope, cm/s
2
Vehicle
G-1
1261
1662
2162
2361
,0.001 0.084 0.734
e’, cm/s
Vehicle
G-1
5.660.2
6.860.3
5.160.4
6.260.3
0.087 0.002 0.846
E/e’
Vehicle
G-1
11.760.5
10.660.3
13.561.5
11.860.8
0.115 0.12 0.753
Data are expressed as mean 6 SEM. Emax = maximum early transmitral filling
velocity; E dec time = early-filling deceleration time; E dec slope = early-filling
deceleration slope; e’= early mitral annular velocity; E/e’ = early transmitral
filling velocity-to-mitral annular velocity ratio.
doi:10.1371/journal.pone.0015433.t004
Figure 4. G1 treatment for two weeks does not alter salt-
induced increases in collagen deposition. Quantification of
cardiac perivascular collagen content using polarized dark field images.
Data represent mean 6 SEM. *** P,0.001 (Salt effect).
doi:10.1371/journal.pone.0015433.g004
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present study can be attributed to the presence of the endogenous
ligand for GPER, estradiol. Although we did not assess circulating
17-b estradiol in the current study, we previously reported that
serum estrogen levels are not changed with chronic salt loading
[18]. Recently, we showed that chronic G-1 administration in
ovariectomized mRen2.Lewis females with exacerbated hyperten-
sion significantly lowers systolic blood pressure to estrogen-intact
levels but does not alter blood pressure in estrogen-intact
littermates [15]. In addition, while the cardiac structural and
functional effects of G-1 may also have been blunted by the
presence of endogenous estradiol, the HS-induced increase in
cardiac GPER expression may have allowed activation of the
receptor in estrogen-intact rats.
A few limitations can be identified in this study. Although we
found statistically significant differences in functional and
structural outcomes, particularly early mitral annular descent
and relative wall thickness, respectively, one potential concern is
that our study may have been underpowered to reliably detect the
effects of G-1 on blood pressure. Limited pilot data for a priori
power analysis using G-1 under high salt conditions existed.
Nevertheless, to place the differences in context, we observed a
28% increase in systolic blood pressure between salt conditions.
Whereas, the G-1 differences in blood pressure ranged between
28% to 6% over the treatment period. These differences are
unlikely to be clinically relevant even with a larger sample.
Certainly, noninvasive blood pressure monitoring is less sensitive
than radiotelemetry. However, this methodology was first
Figure 5. GPER activation with G1 improves myocardial relaxation in normal- and salt-fed mRen2.Lewis females. a. Data represent
mean 6 SEM. e’/a9 = early mitral annular velocity-to-late mitral annular velocity ratio. # P,0.05 compared to NS +G-1 (Salt x G-1 interaction:
P=0.036). b. Representative tissue Doppler images of early (e’) and late (a’) septal mitral annular velocities from each treatment group.
doi:10.1371/journal.pone.0015433.g005
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mography has been reliably been used for conscious recordings in
well-trained rats in our laboratory and that of others for the past
30 years, and it is well-accepted in hypertension research. Finally,
the dose and duration of treatment of G-1 was based on our
studies in the ovariectomized mRen2.Lewis rat [15]. Whether a
prolonged duration or higher dose of G-1 could reduce blood
pressure in this estrogen-intact, HS-fed model is not known. Dose-
response studies are currently underway. Additionally, the
structural effects of G-1 were only detected in the myocytes
following this two-week regimen. We do not know beyond this
time period, what effects there may be on fibrosis and collagen
content, which may also change with a longer treatment period.
Taken together, these data provide the first evidence for a
cardioprotective role for GPER in the hypertensive, salt-sensitive
female mRen2.Lewis rat. Activation of this novel estrogen receptor
attenuated diastolic dysfunction and cardiac hypertrophy in
hypertensive female rats without requisite reductions in blood
pressure. Given the lack of adequate therapeutic strategies for the
treatment of diastolic dysfunction in females, targeting of GPER
may elicit estrogenic benefits in the cardiovascular system.
Clinically, GPER activation may offer a new hormone replace-
ment approach providing less adverse effects than traditional
therapy targeting all estrogen receptors.
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